Vitamin D3 to Treat COVID-19: Different Disease, Same Answer
JAMA
.
2021 Mar 16;325(11):1047-1048.
doi: 10.1001/jama.2020.26850.
Authors
David E Leaf
1
,
Adit A Ginde
2
Affiliations
1
Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
2
Department of Emergency Medicine, University of Colorado School of Medicine, Aurora.
PMID:
33595641
PMCID:
PMC8412177
DOI:
10.1001/jama.2020.26850
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Cholecalciferol* / therapeutic use
Hospitals
Humans
Length of Stay
SARS-CoV-2
Vitamin D
Substances
Vitamin D
Cholecalciferol
Grants and funding
R01 HL144566/HL/NHLBI NIH HHS/United States
UL1 TR002243/TR/NCATS NIH HHS/United States
U01 HL123010/HL/NHLBI NIH HHS/United States
OT2 HL156812/HL/NHLBI NIH HHS/United States
R01 DK125786/DK/NIDDK NIH HHS/United States
R01 HL149422/HL/NHLBI NIH HHS/United States